Delivering dependable healthcare origination worldwide is more challenging and complex than ever.
Pars Bioscience, is wholly owned by Dr. Rafie Hamidpour, Ph.D..
We are a Kansas Corporation which has done research and development since 2004. The business has been doing research on Pharmacological studies that have demonstrated saffron extracts have anti-tumor effects and inhibit the growth of human cancer cells.
This business plan is being used to explore Investigation of Saffron as a Nutritional Supplement for use in Cancer Treatments. The purpose of this project is to investigate saffron, and the processes used to prepare it, as a nutritional supplement for use in treating cancer.
Initially, a literature review of saffron and its application in cancer treatment will be conducted. After literature review, different preparations of saffron will be analyzed as a nutritional supplement. Concentration of the main active components of saffron will also be determined for each preparation.
An important element of anticancer drug development using herbs is the main core of our research. The aim of this research is to provide an updated overview of experimental in vitro and in vivo investigations focused on the anticancer activity of saffron (Crocus sativus L.) and its principal ingredients. Potential use of these natural agents in cancer therapy and chemo preventive trials is also discussed.